by DiaCarta Inc. | Feb 26, 2014 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ February ❯ DiaCarta Inc. Receives CE Mark for Its Proprietary IVD Cancer Mutation Tests: KRAS, NRAS, EGFR and More FollowFollow DiaCarta, a technology-driven translational genomics and...
